Effect of iron status on fertility of woman in relation with certain hormones and other parameters
DOI:
https://doi.org/10.36320/ajb/v10.i1.8211Keywords:
iron status, hormones, fertile womenAbstract
Seventy six subfertile women and thirty fertile women (control group) enrolled in this study. The subfertile women subdivided into two subgroups according to the cause of subfertility: first group ovarian dysfunction (OD) either due to polycystic ovary syndrom (PCOS) or due to other cause (OC) likes anovulation, hyperprolactenemia, premature ovarian failure. Second group: unexplained infertility, their age range (16-40) yr. At day 3 of menstrual cycle (MC) estimation of serum level of multiple hormones like luteinized (LH), follicle stimulating (FSH), estradiole (E2), prolactin (PRL), testosterone, iron status (serum iron, serum ferrtin and total iron binding capacity TIBC) , while at day 13 of MC, estimation of serum levels of LH, serum leptin, glutathione, iron status .Comparison of iron status between fertile and subfertile women at day 13 of MC revealed significant increase in serum ferritin level in women with PCOS. Assessment the serum levels of certain hormones in fertile and subfertile women in those having serum ferritin level less than normal value at day 3 of MC show the following: significantly higher serum testosterone level in PCOS group, also significantly higher serum prolactine level in group of OD due to O.C. as compared with fertile group. Assessment the serum levels of certain hormones in fertile and subfertile women in those having serum ferritin level higher than normal value at day 3 of MC show significantly higher serum prolactine level in group of OD due to O.C. as compared with fertile group. Assessment the serum levels of certain hormones in those having serum ferritin level less than normal value at day 13 of MC, shows significant decrease in LH in women with OD due to O.C. as compared with fertile group.
Conclusions: It was concluded that the decrease in serum ferritin levels in the blood may be associated directly or indirectly with subfertility caused by ovarian dysfunction
Downloads
References
Gurunath, S.; Pandian, Z.; Anderson, R. A.; Bhattacharya, S. (2011). "Defining infertility--a systematic review of prevalence studies". Human Reproduction Update 17 (5): 575.
Cooper, T.G.; Noonan, E. and Von Eckardstein, S. (2010): "World Health Organization reference values for human semen characteristics". Hum. Reprod. Update 16 (3): 231–45.
Gnoth, C.; Godehardt, E.; Frank-Herrmann, P.; Friol, K.; Tigges, J. Freundl, G. (2005): Definition and prevalence of subfertility and infertility. Hum Reprod. 20(5):1144-7.
Merekar Abhijit, N., Pattan, S. R. Kuchekar, B. S., (2009):female infertility–causes and their diagnostic tests. International Journal of Pharma Research and Development. Vol. (8).
Boomsma, C.M.; Fauser, B.C. and Macklon, N.S. (2008): "Pregnancy complications in women with polycystic ovary syndrome". Semin. Reprod. Med. 26 (1): 72–84
Kunz G, Leyendecker G. (2001): Uterine peristaltic activity during the menstrual cycle: characterization, regulation, function and dysfunction. Reprod Biomed; 4: 5–9.
Thiel, C. & Goss, D.J. (2009): Living with iron (and oxygen): questions and answers about iron homeostasis. Chem Rev,Vol. 109, No.10, pp.4568-79.
Wang, J. & Pantopoulos, K. (2011): Regulation of Cellular Iron Metabolism, Biochem J, Vol.434, pp: 365-81.
He, X.; Hahn, P.; Lacovelli, J.; Wong, R.; King, C.; Bhisitkul, R.; (2007): Iron Homeostasis and Toxicity in Retinal Degeneration. Prog Retin Eye Res, Vol.26, No.6, pp: 649-73.
Eschbach, J.W. (2005): Iron requirements in erythropoietin therapy. Best Pract Res Clin Haematol. (18): 347-61.
Chavarro, J. E.; Rich-Edwards, J.W.; Rosner B. A. and Willett. W. C. (2006): "Iron Intake and Risk of Ovulatory Infertility." Obstet Gynecol. 108.5 1145-52.
Westphal, L.M., Polan, M.L. and Trant, A.S. (2004): A nutritional supplement for improving fertility in women: a pilot study. Journal of Reproductive Medicine, 49: 289-93.
Mathur, R. and Sharma, (1995): Correction of anemia and iron deficiency in vegetarians by administration of ascorbic acid. Indian J. Physiol. Pharmacol., 39(4): 403-6.
Wessling-Resnick, M. (2010): Iron Homeostasis and Inflammatory Response. Ann Rev Nutr, Vol.30, pp: 105-22.
Walker, S. W. (2010): Haematological values; Laboratory reference ranges. Ch. 28. In: Davidson's Principle and Practice of Medicine. Colledge, N. R.; Walker, B. R.; Ralston, S. H. (eds). 21st. ed. Churchill Livingstone. PP: 1293-1298.
Briggs DA, Sharp DJ, Miller D, Gosden RG (2000): Transferrin in the developing ovarian follicle: evidence for de-novo expression by granulosa cells. Mol Hum Reprod;5: 1107–14
Adamson, J.W. (2008): Nutritional iron balance. Ch. 98. In: Harrison's Principles of Internal Medicine. Fauci, A.S.; Kasper, D.L.; Longo, D.L. 17th ed. Mc Graw-Hill Companies. PP: 629-34.
Sharifi, F., Mazloomi, S. and Mousavinasab, N. (2011): High Serum Ferritin Concentrations in Polycystic Ovary Syndrome Is Not Related to Insulin Resistance. IRANIAN JOURNAL OF DIABETES AND OBESITY, VOLUME 3, NUMBER 2.
Escobar-Morreale, H.F., Luque-Ramírez, M., Álvarez-Blasco, F., Botella-Carretero, J.I., Sancho, J. and San Millán, J.L. (2005): Body iron stores are increased in overweight and obese women with polycystic ovary syndrome. Diabetes Care; 28(8):2042-4.
Martínez-García, M.A., Luque-Ramírez, M., San-Millán, J.L. and Escobar-Morreale, H.F. (2009): Body iron stores and glucose intolerance in premenopausal women: role of hyperandrogenism, insulin resistance, and genomic variants related to inflammation, oxidative stress, and iron metabolism. Diabetes Care.32 (8):1525-30.
Sathiyanarayanan, S., Shyam Sundar, J., Madhankumar, E.K, Praneetha, A., Kalaiselvi, S., Gopinath, P.M., Dakshayani, D., Krithika Devi, J, Sankar, C. and Ramesh, U. (2014): A study on significant biochemical changes in the serum of infertile women Volume-2 Number 2 pp.96-115.
Calls, J. C.; Phiri, K. S. and Faragher, E. B. (2008): "Sever anemia in Malawian children." N. Engl. J. Med. 358(9): 888-99.
Guillebaud, J; Enda McVeigh; Roy Homburg (2008): Oxford handbook of reproductive medicine and family planning Page: 54. Oxford University Press
Nisenblast, V. and Norman, R.J. (2009): Androgens and polycystic ovary syndrome. Curr Opin Endocrinol Diabetes Obes 16: 224–31
Baird, D. T.; Balen, A.; Escobar-Morreale, H. F.; Evers, J. et al. (2012): "Health and fertility in World Health Organization group 2 anovulatory women". Human Reproduction Update 18 (5): 586.
hibli-rahhal and Schlechte, J. (2011): Hyperprolactinemia and infertility. Endocrinol Metab Clin North Am. ISBN: 40483746
Klibanski, A (2010): Clinical practice. Prolactinomas. N Engl JMed 362:1219–26.
Crosignani, P. G. (1999): Management of hyperprolactinemia in infertility.J Reprod Med. 44(12 Suppl):1116-20.
Charlotte, S.; Justine, B.; Nadège, C.; Virginie, T.; Alain, C.; (2012): Hyperprolactinemia-induced ovarian acyclicity is reversed by kisspeptin administration. Journal of Clinical Investigation, 122 (10): 3791.
Artini, P.G.; Monteleone, P.; Toldin, M.R.P.; Matteucci, C.; Ruggiero, M.; (2007): Growth factors and folliculogenesis in polycystic ovary patients. Expert Rev Endocrinol Metab.; (2):215–23.
Wiksten-Almströmer, M., Hirschberg, A.L. and Hagenfeldt, K. (2007): "Menstrual disorders and associated factors among adolescent girls visiting a youth clinic". Acta Obstet Gynecol Scand. 86 (1): 65–72.
Georgios, A.; Eleni, K.; Ioannis, S.; Vassilios, L.; Constantinos, L.; (2005): Serum and follicular fluid leptin levels are correlated with human embryo quality. Reproduction. (130): 917–21.
De Placido, G.; Alviggi, C.; Clarizia, R.; Mollo, A.; Alviggi, E (2006): Intra-follicular leptin concentration as a predictive factor for in vitro oocyte fertilization. J Endocrinol Invest.(29): 719–26.
Li, M.G.; Ding, G.L.; Dong, M.Y.; (2007): Association of serum and follicular fluid leptin concentrations with granulosa cell phosphorylated. J Clin Endocrinol Metab. 92:4771–6.
Mantzoros, C.S., Cramer, D.W., Liberman, R.F. and Barbieri RL. (2000): Predictive value of serum and follicular fluid leptin concentrations during assisted reproductive cycles. Hum Reprod 15:539–44.
Montecinos, V.; Guzman, P.; Barra, V.; (2007): Vitamin C is an essential antioxidant that enhances survival of oxidatively stressed human vascular endothelial cells. J. Biol. Chem., vol., 282(21): 15506-15.
.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2018 Sami Rehem Al-Katib, Maisem Mohammed Hussein Al-Kaabi, Aseel Jassim Al-Bderi, Wasen Ghasi Al-Safi
This work is licensed under a Creative Commons Attribution 4.0 International License.
which allows users to copy, create extracts, abstracts, and new works from the Article, alter and revise the Article, and make commercial use of the Article (including reuse and/or resale of the Article by commercial entities), provided the user gives appropriate credit (with a link to the formal publication through the relevant DOI), provides a link to the license, indicates if changes were made and the licensor is not represented as endorsing the use made of the work.
